| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965828 | Vaccine | 2013 | 8 Pages |
Abstract
The HSV vaccine had an acceptable safety profile, and was well tolerated and immunogenic when administered to girls aged 10-17 years regardless of age or HSV pre-vaccination serostatus.
Keywords
HSV-2GlaxoSmithKlineHSV-1NOCDGMCGSKMPLHAVHSVTVCAS04GD2IgGHSV vaccine95% CIATPAlumSafetyimmunoglobulin Gaccording to protocolGenital herpesELISAEnzyme-linked immunosorbent assay95% confidence intervalMonophosphoryl lipid AGeometric mean concentrationAluminium hydroxideELISA unitsinternational unitshepatitis A vaccineherpes simplex virusHerpes simplex virus type 1herpes simplex virus type 2optical densitytotal vaccinated cohort
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
xxx xxx, The HSV-040 Study Group The HSV-040 Study Group,